Efficacy of Tyrosine Kinase Inhibitor Therapy in a Chemotherapy-refractory B-cell Precursor Acute Lymphoblastic Leukemia With ZC3HAV1-ABL2 Fusion

被引：6
|
作者：
Decool, Gauthier [1 ,2 ]
Domenech, Carine [3 ,4 ]
Grardel, Nathalie [1 ]
Plesa, Adriana [5 ]
Raczkiewicz, Imelda [1 ]
Ducourneau, Benoit [1 ]
Ruminy, Philippe [6 ]
Pages, Marie-Pierre [5 ]
Girard, Sandrine [5 ]
Fenwarth, Laurene [1 ,2 ]
Preudhomme, Claude [1 ,2 ]
Bertrand, Yves [3 ,4 ]
Duployez, Nicolas [1 ,2 ]
机构：
[1] CHU Lille, Biol & Pathol Ctr, Lab Hematol, Lille, France
[2] Canc Res Inst, INSERM UMR S 1172, Lille, France
[3] Hosp Civils Lyon, IHOP, Dept Pediat Hematol, Lyon, France
[4] Claude Bernard Univ, Lyon, France
[5] Hosp Civils Lyon, Lyon Sud Hosp, Lab Hematol, Pierre Benite, France
[6] Ctr Henri Becquerel, Inst Res & Innovat Biomed, INSERM U918, Rouen, France
来源：
HEMASPHERE | 2019年 / 3卷 / 03期
关键词：
RESIDUAL DISEASE; CLASSIFICATION; IMATINIB; COMPLEX;
D O I：
10.1097/HS9.0000000000000193
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：3
相关论文
共 14 条
  • [1] Poor responses to tyrosine kinase inhibitors in a child with precursor B-cell acute lymphoblastic leukemia with SNX2-ABL1 chimeric transcript
    Masuzawa, Aki
    Kiyotani, Chikako
    Osumi, Tomoo
    Shioda, Yoko
    Iijima, Kazutoshi
    Tomita, Osamu
    Nakabayashi, Kazuhiko
    Oboki, Keisuke
    Yasuda, Kazuki
    Sakamoto, Hiromi
    Ichikawa, Hitoshi
    Hata, Kenichiro
    Yoshida, Teruhiko
    Matsumoto, Kenji
    Kiyokawa, Nobutaka
    Mori, Tetsuya
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 92 (03) : 263 - 267
  • [2] Beneficial tyrosine kinase inhibitor therapy in a patient with relapsed BCR-ABL1-like acute lymphoblastic leukemia with CCDC88C-PDGFRB fusion
    Shuki Oya
    Satoshi Morishige
    Hidetoshi Ozawa
    Kensuke Sasaki
    Yuichiro Semba
    Yoshitaka Yamasaki
    Takayuki Nakamura
    Kazutoshi Aoyama
    Ritsuko Seki
    Fumihiko Mouri
    Koichi Osaki
    Toshihiro Miyamoto
    Takahiro Maeda
    Koji Nagafuji
    International Journal of Hematology, 2021, 113 : 285 - 289
  • [3] A variant e13a3 BCR-ABL1 fusion transcript in refractory adult B-cell acute lymphoblastic leukemia achieving complete remission with CAR-Tcell therapy
    Phan, Chin Lee
    Tan, Siew Ngoh
    Tan, Sen Mui
    Abd Kadir, Sharifah Shahnaz Syed
    Ramli, Nur Liyana Mohd
    Lim, Teck Onn
    Ng, Ching Ching
    CANCER GENETICS, 2021, 250 : 20 - 24
  • [4] Combination therapy of BCR-ABL-positive B cell acute lymphoblastic leukemia by tyrosine kinase inhibitor dasatinib and c-JUN N-terminal kinase inhibition
    Xiao, Xinhua
    Liu, Ping
    Li, Donghe
    Xia, Zhizhou
    Wang, Peihong
    Zhang, Xiuli
    Liu, Mingzhu
    Liao, Lujian
    Jiao, Bo
    Ren, Ruibao
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [5] Beneficial tyrosine kinase inhibitor therapy in a patient with relapsedBCR-ABL1-like acute lymphoblastic leukemia withCCDC88C-PDGFRBfusion
    Oya, Shuki
    Morishige, Satoshi
    Ozawa, Hidetoshi
    Sasaki, Kensuke
    Semba, Yuichiro
    Yamasaki, Yoshitaka
    Nakamura, Takayuki
    Aoyama, Kazutoshi
    Seki, Ritsuko
    Mouri, Fumihiko
    Osaki, Koichi
    Miyamoto, Toshihiro
    Maeda, Takahiro
    Nagafuji, Koji
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 113 (02) : 285 - 289
  • [6] BCR::ABL1-Like B-Cell Acute Lymphoblastic Leukemia with BCR::PDGFRA Fusion: A Case Report and Literature Review
    Hua, Jiamin
    Yan, Han
    Qian, Xiangyu
    Gao, Dongyan
    Yang, Bo
    Xu, Yubing
    Li, Jianfeng
    Weng, Xiangqin
    Zhu, Yongmei
    Wang, Jin
    ACTA HAEMATOLOGICA, 2024, 147 (04) : 467 - 474
  • [7] Case Report: Specific ABL-Inhibitor Imatinib Is an Effective Targeted Agent as the First Line Therapy to Treat B-Cell Acute Lymphoblastic Leukemia With a Cryptic NUP214::ABL1 Gene Fusion
    Stukaite-Ruibiene, Egle
    Norvilas, Rimvydas
    Dirse, Vaidas
    Stankeviciene, Sigita
    Vaitkeviciene, Goda Elizabeta
    PATHOLOGY & ONCOLOGY RESEARCH, 2022, 28
  • [8] A case report of a truncated ABL1 mutation in 2 cases with Philadelphia chromosome-positive B cell precursor acute lymphoblastic leukemia
    Kato, Kana
    Takagi, Shinsuke
    Takano, Hirofumi
    Tsunoda, Shinichi
    Watanabe, Otoya
    Yamaguchi, Kyosuke
    Kageyama, Kosei
    Kaji, Daisuke
    Taya, Yuki
    Nishida, Aya
    Ishiwata, Kazuya
    Yamamoto, Hisashi
    Yamamoto, Go
    Asano-Mori, Yuki
    Koike, Yukako
    Makino, Shigeyoshi
    Wake, Atsushi
    Taniguchi, Shuichi
    Uchida, Naoyuki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 119 (02) : 205 - 209
  • [9] Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort study
    den Boer, Monique L.
    Cario, Gunnar
    Moorman, Anthony V.
    Boer, Judith M.
    de Groot-Kruseman, Hester A.
    Fiocco, Marta
    Escherich, Gabriele
    Imamura, Toshihiko
    Yeoh, Allen
    Sutton, Rosemary
    Dalla-Pozza, Luciano
    Kiyokawa, Nobutaka
    Schrappe, Martin
    Roberts, Kathryn G.
    Mullighan, Charles G.
    Hunger, Stephen P.
    Vora, Ajay
    Attarbaschi, Andishe
    Zaliova, Marketa
    Elitzur, Sara
    Cazzaniga, Giovanni
    Biondi, Andrea
    Loh, Mignon L.
    Pieters, Rob
    LANCET HAEMATOLOGY, 2021, 8 (01): : E55 - E66
  • [10] BCR-ABL fusion protein detection in peripheral blood and bone marrow samples of adult precursor B-cell acute lymphoblastic leukemia patients using the flow cytometric immunobead assay
    Grigoriou, Eirini E.
    Psarra, Katerina K.
    Garofalaki, Maria K.
    Tziotziou, Eirini C.
    Papasteriades, Chryssa A.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2012, 50 (09) : 1657 - 1663
12